Akildia Diabetic Foot Cream
See also our shoes for diabetics - lowest prices on the web.
Specifically Designed For The Care of Diabetic Feet.
Speeds Tissue Repair. Improves the Skin's Natural Defences. Prevents Skin Lesions and Hyperkeratosis.
In a study of diabetic runners, 80% reported no pain after using Akildia once a day for 3 months. See below for amazing results in clinical trials.
The number one cream for diabetic foot care.
Akildia is the result of collaboration between diabetologists, podiatrists and pharmacists. It is recommended in hospitals, and is recognised by The French Diabetes Association.
BENIFITS:
- Protects skin against harsh external factors.
- Prevents dehydration and limits the risk of hyperkeratosis.
- Preserves the skin’s barrier function.
- Speeds tissue regeneration
ACTIVE INGREDIENTS:
- PCA Lipoaminoacid - Soothes and maintains the skin's physiological balance
- Natural Shea Butter - Healing, moisturizing, anti-inflammatory
- Centella Asiatica - Healing, anti-oedema, veinotonic
- Vitamin A - Encourages cell renewal and helps prevent Hyperkeratosis
- Vaseline/Lanolin complex in a non-occlusive o/w emulsion - Moisturizes
- Essential Fatty Acids - Restores the Hydro-Lipid barrier
DIABETES:
50% of leg amputations are performed on diabetics.
The risk of foot infections is 40 times higher in diabetics.
Risk of gangrene is 17 times higher in diabetics.
25% of diabetic hospitalisations are the result of FOOT problems.
PREVENTION IS KEY:
Regular screening for neuropathy and arteriopathy.
Monthly pedicures, daily foot examinations.
Daily use of a foot product to prevent hyperkeratosis, moisturize the skin and retain its protective role.
Proven Efficacy In Clinical Trials
A Study of 10 Diabetic Runners
Results in Pain Reduction After 3 Months Using Akildia Once Per Day
A Study of 50 Diabetic Patients
Diabetology Department, Podiatric Unit, Foundation Hotel Dieu Du Creusot, Le Creusot, France.
Doctor S Clavel.
100% leg neuropathy
64% macro-angiopathy
60% major foot disorders (ulcers, necrosis etc)
40% minor trophic skin disorder
Results After 2 Months Using Akildia Diabetic Foot Cream Once Per Day
Reduction of Hyperkeratosis and Dryness
55.3% = Excellent
31.9% = Good
12.8% = Average
Excellent skin tolerance in 96% of patients
Improvement in skin suppleness and elasticity.
Dr Clavel's conclusion "We can only hope that Akildia becomes available on the market."
Double-Blind Versus Placebo
Conducted in Sweden by Doctor Skarberg.
A Study of 24 Diabetic Patients
70.8% leg neuropathy
50% arteriopathy
91.7% skin dryness
75% hyperkeratosis
Results After 3 Months Using Akildia Twice Per Day (Right foot Akildia, Left foot placebo)
Reduction of skin dryness:
86.4% = Akildia
27.3% = Placebo
Reduction of Hyperkeratosis:
88.9% = Akildia
33.3% = Placebo
Improvement in Skin Sensitivity (using filament method):
70.6% = Akildia
17.6% = Placebo
Conclusions: Significant difference compared to placebo. Good tolerance.